Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry

David J Dexter1, Herman Kado2, Jonathan Schor3

  • 1Sentara Vascular Specialists, Norfolk, VA.

Insights

The ClotTriever System effectively removed thrombus in 86% of patients with lower extremity deep vein thrombosis (DVT). This all-comer study showed sustained clinical improvements and a favorable safety profile at six months.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Medical Device Technology

Background:

  • Deep vein thrombosis (DVT) affects a significant patient population, with varying chronicity and treatment challenges.
  • Current treatment options for DVT may have limitations, particularly in "all-comer" patient groups.
  • The ClotTriever System offers a minimally invasive approach for mechanical thrombectomy.

Purpose of the Study:

  • To assess the safety and effectiveness of the ClotTriever System in an all-comer population with lower extremity DVT.
  • To evaluate thrombus removal rates, safety outcomes, and long-term clinical improvements.
  • To analyze outcomes across a spectrum of thrombus chronicity.

Main Methods:

  • Prospective, single-arm CLOUT registry study of 250 patients with lower extremity DVT.
  • Inclusion of diverse patient profiles, including those with bilateral DVT, failed prior treatments, and varied symptom durations.
  • Primary endpoint: complete or near-complete thrombus removal (≥75%) assessed by Marder scores; secondary endpoints: safety events and clinical outcomes (post-thrombotic syndrome, pain, quality of life) at 6 months.

Main Results:

  • High effectiveness: 86% of limbs achieved complete or near-complete thrombus removal.
  • Favorable safety: Only one device-related serious adverse event reported within 30 days.
  • Significant clinical improvements: Sustained reductions in post-thrombotic syndrome (24% at 6 months), pain, and improved quality of life.
  • Efficient procedure: Median thrombectomy time of 28 minutes, with 99.6% treated in a single session, and no patients requiring thrombolytics.

Conclusions:

  • The CLOUT registry demonstrates the ClotTriever System's favorable safety and effectiveness in an all-comer DVT population.
  • The system achieves high rates of thrombus removal across acute, subacute, and chronic DVT.
  • Sustained clinical benefits and improvements in quality of life are observed at six months post-treatment.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
43
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
53
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
41
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
58
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
42